Cufstik AM Drop contains Ambroxol 7.5mg + Guaifenesin 12.5mg + Terbutaline 0.25mg, a combination used for relieving cough, loosening mucus, and easing bronchial spasms. It is effective in improving airway clearance and reducing respiratory discomfort.
Ambroxol works by breaking down mucus and facilitating its removal from the respiratory tract, Guaifenesin thins and loosens phlegm, while Terbutaline relaxes bronchial smooth muscles, improving airflow and easing breathing. This multi-action combination provides fast symptomatic relief.
This drop is commonly prescribed for patients with productive cough, bronchitis, and mild asthma, ensuring safer and convenient oral dosing. Its syrup-like liquid formulation is suitable for both children and adults.
For PCD pharma franchise partners, Cufstik AM Drop is a high-demand respiratory product, available at the best price for PCD pharma franchise. Its clinical efficacy, strong prescriber trust, and wide patient acceptance make it a valuable addition to any cough and pulmonary care product portfolio.